Conducting Preclinical Abuse Liability Screening in Only One Sex: Making a Case for “Reasonable Exclusion” (original) (raw)

Principles of drug abuse liability assessment in laboratory animals

2003

NIH initiative to balance sex of animals in preclinical studies: generative questions to guide policy, implementation, and metrics

Goran Sandberg, M. Iruela-arispe, Jill Becker

Biology of Sex Differences, 2014

View PDFchevron_right

The gold-standard in preclinical abuse liability testing: It's all relative

Zachary Zimmermann

Journal of Pharmacological and Toxicological Methods, 2018

View PDFchevron_right

Evaluating the National Institutes of Health's Sex as a Biological Variable Policy: Conflicting Accounts from the Front Lines of Animal Research

rebecca walker

Journal of Women's Health

View PDFchevron_right

Laboratory Animal Science, Welfare and Ethics in Pharmacology and Toxicology

Peter Sandøe

Pharmacology & Toxicology, 1997

View PDFchevron_right

Humane endpoints for laboratory animals used in regulatory testing

William Stokes

ILAR journal / National Research Council, Institute of Laboratory Animal Resources, 2002

View PDFchevron_right

Considering sex as a biological variable in preclinical research

Jill Becker

FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2016

View PDFchevron_right

Method of data interpretation for the determination of abuse liability in rodent self-administration studies under the FDA guidance document

Zachary Zimmermann

Journal of Pharmacological and Toxicological Methods, 2017

View PDFchevron_right

Pharmaceutical toxicology: Designing studies to reduce animal use, while maximizing human translation

Jessica Couch, Alan Hoberman

Regulatory Toxicology and Pharmacology, 2013

View PDFchevron_right

Animal testing: still essential for scientific research

Angela Garcia

View PDFchevron_right

ANIMAL TESTING

Sharlene Tapia

View PDFchevron_right

Pharmaceutical toxicology: Designing studies to reduce animal use, while maximizing human translation(MAZEN SAEED)

Mazen Alzoriqy

View PDFchevron_right

Systematic Reviews of Animal Experiments Demonstrate Poor Human Clinical and Toxicological Utility

Andrew Knight

ATLA-NOTTINGHAM-, 2007

View PDFchevron_right

A Discussion on Experiments and Experimentation: NIH to Balance Sex in Cell and Animal Studies

Banu Subramaniam

Catalyst: Feminism, Theory, Technoscience

View PDFchevron_right

In further defense of nonclinical abuse liability testing of biologics

Zachary Zimmermann

Regulatory Toxicology and Pharmacology, 2018

View PDFchevron_right

The international symposium on regulatory testing and animal welfare: recommendations on best scientific practices for subchronic/chronic toxicity and carcinogenicity testing

Tim Morris

ILAR journal / National Research Council, Institute of Laboratory Animal Resources, 2002

View PDFchevron_right

The Validation and Acceptance of Alternatives to Animal Testing

J. Fentem

Toxicology in Vitro, 1999

View PDFchevron_right

The ICLAS/CCAC International Symposium on Regulatory Testing and Animal Welfare

William Stokes

Alternatives to laboratory animals : ATLA, 2004

View PDFchevron_right

Current concepts of Harm–Benefit Analysis of Animal Experiments – Report from the AALAS–FELASA Working Group on Harm–Benefit Analysis – Part 1

Aurora Brønstad

Laboratory Animals, 2016

View PDFchevron_right

The International Symposium on Regulatory Testing and Animal Welfare: Recommendations on Best Scientific Practices for Animal Care Committees anc Animal Use Oversight

Jonathan Richmond

ILAR Journal, 2002

View PDFchevron_right

FDA perspectives on the use of teratology data for human risk assessment*1

Vasilios Frankos

Fundamental and applied toxicology, 1985

View PDFchevron_right

An Approach to Minimise Dog Use in Regulatory Toxicology: Production of a Best Practice Guide to Study Design

بهروز اخلاقی

Alternatives to Laboratory Animals, 2004

View PDFchevron_right

Moving Away From Animal Testing: The Case Against The Biological Reactivity Test

Tim Sandle

IVT Network, 2021

View PDFchevron_right

Recommendations from a global cross-company data sharing initiative on the incorporation of recovery phase animals in safety assessment studies to support first-in-human clinical trials

klaudia hettinger

2014

View PDFchevron_right

Validating animal models for preclinical research: A scientific and ethical discussion

Peter Sandøe

Alternatives to laboratory animals: ATLA

View PDFchevron_right

SYRCLE’s risk of bias tool for animal studies

Rob de Vries, Merel Ritskes-Hoitinga

BMC Medical Research Methodology, 2014

View PDFchevron_right

A twin transition in regulatory toxicology: moving toward Chemicals 2.0 and phasing out animal testing

Andrew P Worth

Toxicological Sciences, 2024

View PDFchevron_right

Food for thought ... on the evolution of toxicology and the phasing out of animal testing

Thomas Hartung

ALTEX, 2008

View PDFchevron_right

Animal Use in the Safety Evaluation of Chemicals: Harmonization and Emerging Needs

Horst Spielmann

ILAR Journal, 2002

View PDFchevron_right

Laboratory animal welfare

Catia Helena de Almeida Lima Massari

Brazilian Journal of Veterinary Research and Animal Science

View PDFchevron_right

Conducting Preclinical Abuse Liability Screening in Only One Sex: Making a Case for “Reasonable Exclusion” (original) (raw)

Related papers